Global Onychomycosis Drugs Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Table of Contents

1 Onychomycosis Drugs Market Overview

• 1.1 Product Overview and Scope of Onychomycosis Drugs
• 1.2 Classification of Onychomycosis Drugs by Types
  • 1.2.1 Global Onychomycosis Drugs Revenue Comparison by Types (2019-2024)
  • 1.2.2 Global Onychomycosis Drugs Revenue Market Share by Types in 2018
  • 1.2.3 Oral Drugs
  • 1.2.4 Topical Drugs
• 1.3 Global Onychomycosis Drugs Market by Application
  • 1.3.1 Global Onychomycosis Drugs Market Size and Market Share Comparison by Applications (2014-2024)
  • 1.3.2 Hospital Pharmacies
  • 1.3.3 Retail Pharmacies
  • 1.3.4 Online Pharmacies
• 1.4 Global Onychomycosis Drugs Market by Regions
  • 1.4.1 Global Onychomycosis Drugs Market Size (Million USD) Comparison by Regions (2014-2024)
  • 1.4.1 North America (USA, Canada and Mexico) Onychomycosis Drugs Status and Prospect (2014-2024)
  • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Onychomycosis Drugs Status and Prospect (2014-2024)
  • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Onychomycosis Drugs Status and Prospect (2014-2024)
  • 1.4.4 South America (Brazil, Argentina, Colombia) Onychomycosis Drugs Status and Prospect (2014-2024)
  • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Onychomycosis Drugs Status and Prospect (2014-2024)
• 1.5 Global Market Size of Onychomycosis Drugs (2014-2024)

2 Manufacturers Profiles

• 2.1 Pfizer
  • 2.1.1 Business Overview
  • 2.1.2 Onychomycosis Drugs Type and Applications
    • 2.1.2.1 Product A
    • 2.1.2.2 Product B
  • 2.1.3 Pfizer Onychomycosis Drugs Revenue, Gross Margin and Market Share (2017-2018)
• 2.2 Novartis
  • 2.2.1 Business Overview
  • 2.2.2 Onychomycosis Drugs Type and Applications
    • 2.2.2.1 Product A
    • 2.2.2.2 Product B
  • 2.2.3 Novartis Onychomycosis Drugs Revenue, Gross Margin and Market Share (2017-2018)
• 2.3 Johnson & Johnson
  • 2.3.1 Business Overview
  • 2.3.2 Onychomycosis Drugs Type and Applications
    • 2.3.2.1 Product A
    • 2.3.2.2 Product B
  • 2.3.3 Johnson & Johnson Onychomycosis Drugs Revenue, Gross Margin and Market Share (2017-2018)
• 2.4 Bausch Health
  • 2.4.1 Business Overview
  • 2.4.2 Onychomycosis Drugs Type and Applications
    • 2.4.2.1 Product A
    • 2.4.2.2 Product B
  • 2.4.3 Bausch Health Onychomycosis Drugs Revenue, Gross Margin and Market Share (2017-2018)
• 2.5 Bayer
  • 2.5.1 Business Overview
  • 2.5.2 Onychomycosis Drugs Type and Applications
    • 2.5.2.1 Product A
    • 2.5.2.2 Product B
  • 2.5.3 Bayer Onychomycosis Drugs Revenue, Gross Margin and Market Share (2017-2018)
• 2.6 Galderma
  • 2.6.1 Business Overview
  • 2.6.2 Onychomycosis Drugs Type and Applications
    • 2.6.2.1 Product A
    • 2.6.2.2 Product B
  • 2.6.3 Galderma Onychomycosis Drugs Revenue, Gross Margin and Market Share (2017-2018)
• 2.7 Moberg Pharma
  • 2.7.1 Business Overview
  • 2.7.2 Onychomycosis Drugs Type and Applications
    • 2.7.2.1 Product A
    • 2.7.2.2 Product B
  • 2.7.3 Moberg Pharma Onychomycosis Drugs Revenue, Gross Margin and Market Share (2017-2018)
• 2.8 Cipla
  • 2.8.1 Business Overview
  • 2.8.2 Onychomycosis Drugs Type and Applications
    • 2.8.2.1 Product A
    • 2.8.2.2 Product B
  • 2.8.3 Cipla Onychomycosis Drugs Revenue, Gross Margin and Market Share (2017-2018)
• 2.9 Biofrontera
  • 2.9.1 Business Overview
  • 2.9.2 Onychomycosis Drugs Type and Applications
    • 2.9.2.1 Product A
    • 2.9.2.2 Product B
  • 2.9.3 Biofrontera Onychomycosis Drugs Revenue, Gross Margin and Market Share (2017-2018)
• 2.10 Leo Pharma
  • 2.10.1 Business Overview
  • 2.10.2 Onychomycosis Drugs Type and Applications
    • 2.10.2.1 Product A
    • 2.10.2.2 Product B
  • 2.10.3 Leo Pharma Onychomycosis Drugs Revenue, Gross Margin and Market Share (2017-2018)
• 2.11 Dr. Reddy's Laboratories
  • 2.11.1 Business Overview
  • 2.11.2 Onychomycosis Drugs Type and Applications
    • 2.11.2.1 Product A
    • 2.11.2.2 Product B
  • 2.11.3 Dr. Reddy's Laboratories Onychomycosis Drugs Revenue, Gross Margin and Market Share (2017-2018)
• 2.12 Medimetriks Pharmaceuticals
  • 2.12.1 Business Overview
  • 2.12.2 Onychomycosis Drugs Type and Applications
    • 2.12.2.1 Product A
    • 2.12.2.2 Product B
  • 2.12.3 Medimetriks Pharmaceuticals Onychomycosis Drugs Revenue, Gross Margin and Market Share (2017-2018)

3 Global Onychomycosis Drugs Market Competition, by Players

• 3.1 Global Onychomycosis Drugs Revenue and Share by Players (2014-2019)
• 3.2 Market Concentration Rate
  • 3.2.1 Top 5 Onychomycosis Drugs Players Market Share
  • 3.2.2 Top 10 Onychomycosis Drugs Players Market Share
• 3.3 Market Competition Trend

4 Global Onychomycosis Drugs Market Size by Regions

• 4.1 Global Onychomycosis Drugs Revenue and Market Share by Regions
• 4.2 North America Onychomycosis Drugs Revenue and Growth Rate (2014-2019)
• 4.3 Europe Onychomycosis Drugs Revenue and Growth Rate (2014-2019)
• 4.4 Asia-Pacific Onychomycosis Drugs Revenue and Growth Rate (2014-2019)
• 4.5 South America Onychomycosis Drugs Revenue and Growth Rate (2014-2019)
• 4.6 Middle East and Africa Onychomycosis Drugs Revenue and Growth Rate (2014-2019)

5 North America Onychomycosis Drugs Revenue by Countries

• 5.1 North America Onychomycosis Drugs Revenue by Countries (2014-2019)
• 5.2 USA Onychomycosis Drugs Revenue and Growth Rate (2014-2019)
• 5.3 Canada Onychomycosis Drugs Revenue and Growth Rate (2014-2019)
• 5.4 Mexico Onychomycosis Drugs Revenue and Growth Rate (2014-2019)

6 Europe Onychomycosis Drugs Revenue by Countries

• 6.1 Europe Onychomycosis Drugs Revenue by Countries (2014-2019)
• 6.2 Germany Onychomycosis Drugs Revenue and Growth Rate (2014-2019)
• 6.3 UK Onychomycosis Drugs Revenue and Growth Rate (2014-2019)
• 6.4 France Onychomycosis Drugs Revenue and Growth Rate (2014-2019)
• 6.5 Russia Onychomycosis Drugs Revenue and Growth Rate (2014-2019)
• 6.6 Italy Onychomycosis Drugs Revenue and Growth Rate (2014-2019)

7 Asia-Pacific Onychomycosis Drugs Revenue by Countries

• 7.1 Asia-Pacific Onychomycosis Drugs Revenue by Countries (2014-2019)
• 7.2 China Onychomycosis Drugs Revenue and Growth Rate (2014-2019)
• 7.3 Japan Onychomycosis Drugs Revenue and Growth Rate (2014-2019)
• 7.4 Korea Onychomycosis Drugs Revenue and Growth Rate (2014-2019)
• 7.5 India Onychomycosis Drugs Revenue and Growth Rate (2014-2019)
• 7.6 Southeast Asia Onychomycosis Drugs Revenue and Growth Rate (2014-2019)

8 South America Onychomycosis Drugs Revenue by Countries

• 8.1 South America Onychomycosis Drugs Revenue by Countries (2014-2019)
• 8.2 Brazil Onychomycosis Drugs Revenue and Growth Rate (2014-2019)
• 8.3 Argentina Onychomycosis Drugs Revenue and Growth Rate (2014-2019)
• 8.4 Colombia Onychomycosis Drugs Revenue and Growth Rate (2014-2019)

9 Middle East and Africa Revenue Onychomycosis Drugs by Countries

• 9.1 Middle East and Africa Onychomycosis Drugs Revenue by Countries (2014-2019)
• 9.2 Saudi Arabia Onychomycosis Drugs Revenue and Growth Rate (2014-2019)
• 9.3 UAE Onychomycosis Drugs Revenue and Growth Rate (2014-2019)
• 9.4 Egypt Onychomycosis Drugs Revenue and Growth Rate (2014-2019)
• 9.5 Nigeria Onychomycosis Drugs Revenue and Growth Rate (2014-2019)
• 9.6 South Africa Onychomycosis Drugs Revenue and Growth Rate (2014-2019)

10 Global Onychomycosis Drugs Market Segment by Type

• 10.1 Global Onychomycosis Drugs Revenue and Market Share by Type (2014-2019)
• 10.2 Global Onychomycosis Drugs Market Forecast by Type (2019-2024)
• 10.3 Oral Drugs Revenue Growth Rate (2014-2024)
• 10.4 Topical Drugs Revenue Growth Rate (2014-2024)

11 Global Onychomycosis Drugs Market Segment by Application

• 11.1 Global Onychomycosis Drugs Revenue Market Share by Application (2014-2019)
• 11.2 Onychomycosis Drugs Market Forecast by Application (2019-2024)
• 11.3 Hospital Pharmacies Revenue Growth (2014-2019)
• 11.4 Retail Pharmacies Revenue Growth (2014-2019)
• 11.5 Online Pharmacies Revenue Growth (2014-2019)

12 Global Onychomycosis Drugs Market Size Forecast (2019-2024)

• 12.1 Global Onychomycosis Drugs Market Size Forecast (2019-2024)
• 12.2 Global Onychomycosis Drugs Market Forecast by Regions (2019-2024)
• 12.3 North America Onychomycosis Drugs Revenue Market Forecast (2019-2024)
• 12.4 Europe Onychomycosis Drugs Revenue Market Forecast (2019-2024)
• 12.5 Asia-Pacific Onychomycosis Drugs Revenue Market Forecast (2019-2024)
• 12.6 South America Onychomycosis Drugs Revenue Market Forecast (2019-2024)
• 12.7 Middle East and Africa Onychomycosis Drugs Revenue Market Forecast (2019-2024)

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology